company background image
USPH

U.S. Physical TherapyNYSE:USPH Stock Report

Last Price

US$95.25

Market Cap

US$1.2b

7D

1.3%

1Y

-25.5%

Updated

17 Jan, 2022

Data

Company Financials +
USPH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance2/6
Financial Health4/6
Dividends3/6

USPH Stock Overview

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

U.S. Physical Therapy Competitors

Select Medical Holdings

NYSE:SEM

US$3.9b

ATI Physical Therapy

NYSE:ATIP

US$739.7m

CareRx

TSX:CRRX

CA$245.9m

Price History & Performance

Summary of all time highs, changes and price drops for U.S. Physical Therapy
Historical stock prices
Current Share PriceUS$95.25
52 Week HighUS$143.67
52 Week LowUS$84.43
Beta1.42
1 Month Change-2.05%
3 Month Change-10.56%
1 Year Change-25.48%
3 Year Change-12.55%
5 Year Change39.36%
Change since IPO3,841.37%

Recent News & Updates

Jan 06
An Intrinsic Calculation For U.S. Physical Therapy, Inc. (NYSE:USPH) Suggests It's 27% Undervalued

An Intrinsic Calculation For U.S. Physical Therapy, Inc. (NYSE:USPH) Suggests It's 27% Undervalued

In this article we are going to estimate the intrinsic value of U.S. Physical Therapy, Inc. ( NYSE:USPH ) by estimating...

Dec 07
There Are Reasons To Feel Uneasy About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital

There Are Reasons To Feel Uneasy About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Shareholder Returns

USPHUS HealthcareUS Market
7D1.3%0.4%-0.3%
1Y-25.5%16.4%13.7%

Return vs Industry: USPH underperformed the US Healthcare industry which returned 16.4% over the past year.

Return vs Market: USPH underperformed the US Market which returned 13.7% over the past year.

Price Volatility

Is USPH's price volatile compared to industry and market?
USPH volatility
USPH Average Weekly Movement5.8%
Healthcare Industry Average Movement8.0%
Market Average Movement6.6%
10% most volatile stocks in US Market15.9%
10% least volatile stocks in US Market2.4%

Stable Share Price: USPH is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: USPH's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19904,139Chris Readinghttps://www.usph.com

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2020, it operated 544 outpatient physical therapy clinics in 39 states; and managed 38 physical therapy facilities.

U.S. Physical Therapy Fundamentals Summary

How do U.S. Physical Therapy's earnings and revenue compare to its market cap?
USPH fundamental statistics
Market CapUS$1.23b
Earnings (TTM)US$30.51m
Revenue (TTM)US$477.49m

40.3x

P/E Ratio

2.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
USPH income statement (TTM)
RevenueUS$477.49m
Cost of RevenueUS$358.35m
Gross ProfitUS$119.14m
ExpensesUS$88.63m
EarningsUS$30.51m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)2.36
Gross Margin24.95%
Net Profit Margin6.39%
Debt/Equity Ratio8.4%

How did USPH perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

46%

Payout Ratio

Valuation

Is U.S. Physical Therapy undervalued compared to its fair value and its price relative to the market?

25.7%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: USPH ($95.25) is trading below our estimate of fair value ($128.22)

Significantly Below Fair Value: USPH is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: USPH is poor value based on its PE Ratio (40.3x) compared to the US Healthcare industry average (22.3x).

PE vs Market: USPH is poor value based on its PE Ratio (40.3x) compared to the US market (17.4x).


Price to Earnings Growth Ratio

PEG Ratio: USPH is poor value based on its PEG Ratio (2.3x)


Price to Book Ratio

PB vs Industry: USPH is overvalued based on its PB Ratio (4.2x) compared to the US Healthcare industry average (2.7x).


Future Growth

How is U.S. Physical Therapy forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

17.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: USPH's forecast earnings growth (17.5% per year) is above the savings rate (2%).

Earnings vs Market: USPH's earnings (17.5% per year) are forecast to grow faster than the US market (13% per year).

High Growth Earnings: USPH's earnings are forecast to grow, but not significantly.

Revenue vs Market: USPH's revenue (8.5% per year) is forecast to grow slower than the US market (9.3% per year).

High Growth Revenue: USPH's revenue (8.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: USPH's Return on Equity is forecast to be low in 3 years time (16.8%).


Past Performance

How has U.S. Physical Therapy performed over the past 5 years?

11.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: USPH has high quality earnings.

Growing Profit Margin: USPH's current net profit margins (6.4%) are lower than last year (7.1%).


Past Earnings Growth Analysis

Earnings Trend: USPH's earnings have grown by 11.7% per year over the past 5 years.

Accelerating Growth: USPH's earnings growth over the past year (1.3%) is below its 5-year average (11.7% per year).

Earnings vs Industry: USPH earnings growth over the past year (1.3%) underperformed the Healthcare industry 32.5%.


Return on Equity

High ROE: USPH's Return on Equity (14.5%) is considered low.


Financial Health

How is U.S. Physical Therapy's financial position?


Financial Position Analysis

Short Term Liabilities: USPH's short term assets ($79.4M) do not cover its short term liabilities ($81.7M).

Long Term Liabilities: USPH's short term assets ($79.4M) do not cover its long term liabilities ($119.6M).


Debt to Equity History and Analysis

Debt Level: USPH's net debt to equity ratio (3.9%) is considered satisfactory.

Reducing Debt: USPH's debt to equity ratio has reduced from 18.3% to 8.4% over the past 5 years.

Debt Coverage: USPH's debt is well covered by operating cash flow (239%).

Interest Coverage: USPH's interest payments on its debt are well covered by EBIT (96.4x coverage).


Balance Sheet


Dividend

What is U.S. Physical Therapy current dividend yield, its reliability and sustainability?

1.60%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: USPH's dividend (1.6%) is higher than the bottom 25% of dividend payers in the US market (1.32%).

High Dividend: USPH's dividend (1.6%) is low compared to the top 25% of dividend payers in the US market (3.44%).


Stability and Growth of Payments

Stable Dividend: USPH's dividend payments have been volatile in the past 10 years.

Growing Dividend: USPH's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (45.6%), USPH's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

9.5yrs

Average management tenure


CEO

Chris Reading (57 yo)

17.17yrs

Tenure

US$2,961,147

Compensation

Mr. Christopher J. Reading, also known as Chris, has been the Chief Executive Officer and President of US Physical Therapy Inc. since November 1, 2004. Mr. Reading served as the Chief Operating Officer at...


CEO Compensation Analysis

Compensation vs Market: Chris's total compensation ($USD2.96M) is about average for companies of similar size in the US market ($USD3.62M).

Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: USPH's management team is seasoned and experienced (9.5 years average tenure).


Board Members

Experienced Board: USPH's board of directors are seasoned and experienced ( 15.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: USPH insiders have sold more shares than they have bought in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

U.S. Physical Therapy, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: U.S. Physical Therapy, Inc.
  • Ticker: USPH
  • Exchange: NYSE
  • Founded: 1990
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: US$1.230b
  • Shares outstanding: 12.91m
  • Website: https://www.usph.com

Number of Employees


Location

  • U.S. Physical Therapy, Inc.
  • 1300 West Sam Houston Parkway South
  • Suite 300
  • Houston
  • Texas
  • 77042
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/17 23:38
End of Day Share Price2022/01/14 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.